73 related articles for article (PubMed ID: 30005982)
1. Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age.
Ruiz J; Miller AA; Tooze JA; Crane S; Petty WJ; Gajra A; Klepin HD
J Geriatr Oncol; 2019 Jan; 10(1):48-54. PubMed ID: 30005982
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.
AlSendi M; Flynn CR; Khan MR; Selvadurai P; Crown J; McDermott RS; Walshe JM; Fennelly DW; Hanrahan EO; Doherty M; Higgins MJ
Ir J Med Sci; 2024 Feb; 193(1):45-50. PubMed ID: 37450258
[TBL] [Abstract][Full Text] [Related]
3. Association Between Chronologic Age and Geriatric Assessment-Identified Impairments: Findings From the CARE Registry.
Giri S; Al-Obaidi M; Weaver A; Kenzik KM; McDonald A; Clark D; Young-Smith C; Paluri R; Nandagopal L; Gbolahan O; Pergolotti M; Bhatia S; Williams GR
J Natl Compr Canc Netw; 2021 Jun; 19(8):922-927. PubMed ID: 34116502
[TBL] [Abstract][Full Text] [Related]
4. The Role of Baseline Sarcopenia Index in Predicting Chemotherapy-Induced Undesirable Effects and Mortality in Older People with Stage III or IV Non-Small Cell Lung Cancer.
Chen X; Hou L; Shen Y; Wu X; Dong B; Hao Q
J Nutr Health Aging; 2021; 25(7):878-882. PubMed ID: 34409965
[TBL] [Abstract][Full Text] [Related]
5. A Geriatric Assessment Intervention to Reduce Treatment Toxicity Among Older Adults With Advanced Lung Cancer: A Subgroup Analysis From a Cluster Randomized Controlled Trial.
Presley CJ; Mohamed MR; Culakova E; Flannery M; Vibhakar PH; Hoyd R; Amini A; VanderWalde N; Wong ML; Tsubata Y; Spakowicz DJ; Mohile SG
Front Oncol; 2022; 12():835582. PubMed ID: 35433441
[TBL] [Abstract][Full Text] [Related]
6. Toxicity in Older Patients with Cancer Receiving Immunotherapy: An Observational Study.
Tran Van Hoi E; Trompet S; Van Holstein Y; Van Den Bos F; Van Heemst D; Codrington H; Labots G; Lohman S; Ozkan A; Portielje J; Mooijaart SP; De Glas NA; Derks M
Drugs Aging; 2024 May; 41(5):431-441. PubMed ID: 38727992
[TBL] [Abstract][Full Text] [Related]
7. Integrating Frailty Assessment to Enhance Care in Cancer Patients with Borderline Eastern Cooperative Oncology Group Performance Status.
Hsu CC; Hung YS; Yu SM; Hsueh SW; Chou WC
Am J Hosp Palliat Care; 2024 Jan; ():10499091231226062. PubMed ID: 38182134
[TBL] [Abstract][Full Text] [Related]
8. Preoperative frailty screening in elderly patients with non-small cell lung cancer surgery: an essential step for a good surgical outcome.
Antoniu SA; Iacobescu R; Popa AD; Pavel-Tanase M; Stratulat TA
Expert Rev Respir Med; 2024 May; ():1-12. PubMed ID: 38690646
[TBL] [Abstract][Full Text] [Related]
9. A usability and participatory design study for GeRI, an open-source, remote cancer treatment toxicity and frailty monitoring platform for older adults.
Mir N; Curry G; Lee NK; Szmulewitz RZ; Huisingh-Scheetz M
J Geriatr Oncol; 2024 Jan; 15(1):101595. PubMed ID: 37487857
[No Abstract] [Full Text] [Related]
10. Predicting Risk of Severe Toxicity and Early Death in Older Adult Patients Treated with Chemotherapy.
Feliu J; Custodio AB; Pinto-Marín A; Higuera O; Pérez-González M; Del Pino L; Ruiz-Jiménez L; Sánchez-Cabero D; Viera I; Jurado A; Espinosa E
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760638
[TBL] [Abstract][Full Text] [Related]
11. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
[TBL] [Abstract][Full Text] [Related]
12. Prediction of chemotherapy adverse reactions and mortality in older patients with primary lung cancer through frailty index based on routine laboratory data.
Wang Y; Zhang R; Shen Y; Su L; Dong B; Hao Q
Clin Interv Aging; 2019; 14():1187-1197. PubMed ID: 31308642
[TBL] [Abstract][Full Text] [Related]
13. Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.
Friedlaender A; Banna GL; Buffoni L; Addeo A
Curr Oncol Rep; 2019 Nov; 21(12):107. PubMed ID: 31768759
[TBL] [Abstract][Full Text] [Related]
14. Predicting Chemotherapy Toxicity and Death in Older Adults with Colon Cancer: Results of MOST Study.
Retornaz F; Guillem O; Rousseau F; Morvan F; Rinaldi Y; Nahon S; Castagna C; Boulahssass R; Grino M; Gholam D
Oncologist; 2020 Jan; 25(1):e85-e93. PubMed ID: 31387952
[TBL] [Abstract][Full Text] [Related]
15. Obesity survival paradox in cancer patients: Results from the Physical Frailty in older adult cancer patients (PF-EC) study.
Pamoukdjian F; Aparicio T; Canoui-Poitrine F; Duchemann B; Lévy V; Wind P; Ganne N; Sebbane G; Zelek L; Paillaud E
Clin Nutr; 2019 Dec; 38(6):2806-2812. PubMed ID: 30583963
[TBL] [Abstract][Full Text] [Related]
16. Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.
Zambetti BR; Ng T
J Thorac Cardiovasc Surg; 2021 Mar; 161(3):787-788. PubMed ID: 32868059
[No Abstract] [Full Text] [Related]
17. Utility of the modified frailty index in predicting toxicity and cancer outcomes for older adults with advanced pancreatic cancer receiving first-line palliative chemotherapy.
Rittberg R; Zhang H; Lambert P; Kudlovich R; Kim CA; Dawe DE
J Geriatr Oncol; 2021 Jan; 12(1):112-117. PubMed ID: 32798212
[TBL] [Abstract][Full Text] [Related]
18. Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.
Almodovar T; Teixeira E; Barroso A; Soares M; Queiroga HJ; Cavaco-Silva J; Barata F
Pulmonology; 2019; 25(1):40-50. PubMed ID: 30266308
[TBL] [Abstract][Full Text] [Related]
19. Frailty and postoperative complications in older Chinese adults undergoing major thoracic and abdominal surgery.
Han B; Li Q; Chen X
Clin Interv Aging; 2019; 14():947-957. PubMed ID: 31190780
[No Abstract] [Full Text] [Related]
20. Frailty assessment prior to thoracic surgery for lung or esophageal cancer: a feasibility study.
Hirpara DH; Kidane B; Rogalla P; Cypel M; de Perrot M; Keshavjee S; Pierre A; Waddell T; Yasufuku K; Darling GE
Support Care Cancer; 2019 Apr; 27(4):1535-1540. PubMed ID: 30426204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
